Both in Biotechnology
Protalix BioTherapeutics vs Precision BioSciences
Over the past year PLX returned +10.1% and DTIL returned −11.7%; their daily moves had a correlation of 0.11.
PLX +10.1% DTIL −11.7%Growth of $1, one year, split-adjusted
| Metric | PLX | DTIL |
|---|---|---|
| Price | $2.61 | $7.44 |
| Market cap | $210.3M | $205.4M |
| Today | +0.77% | −0.40% |
| 1 month | −5.4% | +18.8% |
| 6 months | +21.4% | +4.1% |
| Year to date | +45.0% | +78.8% |
| 1 year | +13.5% | −10.3% |
| Revenue growth (YoY) | +27.1% | — |
| Gross margin | 61.0% | — |
| Net margin | 19.0% | — |
| P/E (TTM) | 11.1× | — |
| Price / sales | 2.6× | — |
| Net cash | $40.7M | $65.1M |
| Dividend yield | — | — |
| Volatility (60d) | 44.6% | 61.9% |
| Short % of float | 4.7% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).